RHOA and COVID-19: Next, we tested whether RhoA/ROCK activation might mediate HA fragment–induced barrier disruption in lung endothelium by culturing LMVECs in the presence or absence of a ROCK inhibitor (Y27632 ) prior to treatment with either biosynthetic HA4k or COVID-19 HA fragments.